Are first-trimester screening markers altered in assisted reproductive technologies pregnancies?

Current Opinion in Obstetrics and Gynecology

Volumn 23, Issue 3, 2011, Pages 183-189

  Geipel, Annegret ^a   Gembruch, Ulrich ^a   Berg, Christoph ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

assisted reproduction; assisted reproductive technologies; first trimester screening; free human chorionic gonadotropin; intracytoplasmic sperm injection; IVF; nuchal translucency; pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ASSISTES REPRODUCTIVE TECHNIQUE; CONCEPTION; CRYOPRESERVATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MULTIPLE PREGNANCY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRIORITY JOURNAL; REVIEW; SCREENING; TRISOMY 21; TWIN PREGNANCY; ULTRASOUND;

BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY, MULTIPLE; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 79955946106     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3283455972     Document Type: Review

References (51)

1. Weisz B, Rodeck CH. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies. Hum Reprod Update 2006; 12:513-518. (Pubitemid 44288708)
2. Gjerris AC, Loft A, Pinborg A, et al. Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995-2000: a national cohort study. Hum Reprod 2008; 23:1545-1552. (Pubitemid 351809702)
3. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 2004; 328:261-265.
4. Amor DJ, Xu JX, Halliday JL, et al. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Hum Reprod 2009; 24:1330-1338.
5. Williams C, Sutcliffe A. Infant outcomes of assisted reproduction. Early Hum Dev 2009; 85:673-677.
6. Henningsen AK, Pinborg A, Lidegaard O, et al. Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril 2011; 95:959-963.
7. Geipel A, Berg C, Katalinic A, et al. Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod Biomed Online 2004; 8:119-124. (Pubitemid 38100701)
8. Kagan KO, Wright D, Baker A, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31:618-624.
9. Kagan KO, Etchegaray A, Zhou Y, et al. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 34:14-18.
10. Kagan KO, Cicero S, Staboulidou I, et al. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33:259-264.
11. Maiz N, Valencia C, Kagan KO, et al. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33:512-517.
12. Kagan KO, Valencia C, Livanos P, et al. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-0 to 13-6 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33:18-22.
13. Lambert-Messerlian G, Dugoff L, Vidaver J, et al. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat Diagn 2006; 26:672-678. (Pubitemid 44252240)
14. Bender F, Hecken J, Reinsberg J, et al. Altered first-trimester screening markers after IVF/ICSI: no relationship with small-for-gestational-age and number of embryos transferred. Reprod Biomed Online 2010; 20:516-522.
15. Hui PW, Tang MH, Lam YH, et al. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 2005; 25:234-238. (Pubitemid 40432689)
16. Gjerris AC, Loft A, Pinborg A, et al. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 2009; 33:8-17.
17. Engels MA, Kooij M, Schats R, et al. First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction. Prenat Diagn 2010; 30:372-377.
18. Kagan KO, Staboulidou I, Cruz J, et al. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol 2010; 36:542-547.
19. Gjerris AC, Loft A, Pinborg A, et al. First-trimester screening in pregnancies conceived by assisted reproductive technology: significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length. Ultrasound Obstet Gynecol 2008; 32:612-617.
20. Liao AW, Heath V, Kametas N, et al. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16:1501-1504. (Pubitemid 32640332)
21. Ghisoni L, Ferrazzi E, Castagna C, et al. Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 2003; 24:99-103.
22. Bellver J, Lara C, Soares SR, et al. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 2005; 20:2623-2627. (Pubitemid 41222520)
23. Tul N, Novak-Antolic Z. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn 2006; 26:1206-1211. (Pubitemid 46032333)
24. Anckaert E, Schiettecatte J, Sleurs E, et al. First-trimester screening for Down's syndrome after assisted reproductive technology: nonmale factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil Steril 2008; 90:1206-1210.
25. Matilainen M, Peuhkurinen S, Laitinen P, et al. In combined first-trimester Down syndrome screening, the positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies. Fertil Steril 2011; 95:378-381.
26. Kagan KO, Wright D, Spencer K, et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31:493-502.
27. Hui PW, Lam YH, Tang MH, et al. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotropin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 2005; 25:390-393. (Pubitemid 40813781)
28. Laigaard J, Pedersen NG, Larsen SO, et al. ADAM12 in first trimester maternal serum from pregnancies conceived by assisted reproduction techniques (ART). Prenat Diagn 2009; 29:628-629.
29. Ranta JK, Raatikainen K, Romppanen J, et al. Increased time-to-pregnancy and first trimester Down's syndrome screening. Hum Reprod 2010; 25:412-417.
30. Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008; 30:918-949.
31. Pihl K, Larsen T, Krebs L, Christiansen M. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenat Diagn 2008; 28:1131-1135.
32. Papageorghiou AT, Leslie K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol 2007; 19:103-109. (Pubitemid 46412097)
33. Goetzinger KR, Cahill AG, Macones GA, Odibo AO. Association of firsttrimester low PAPP-A levels with preterm birth. Prenat Diagn 2010; 30:309-313.
34. Zhong Y, Bradshaw R, Stanley AP, Odibo AO. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein-A and human chorionic gonadotropin and adverse pregnancy outcomes. Am J Perinatol 2010. [Epub ahead of print]
35. Spencer K, Staboulidou I, Nicolaides KH. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn 2010; 30:235-240.
36. Gjerris AC, Loft A, Pinborg A, et al. The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology. Hum Reprod 2009; 24:55-62.
37. Maymon R, Neeman O, Shulman A, et al. Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble. Prenat Diagn 2005; 25:746-750. (Pubitemid 41405942)
38. Vandecruys H, Faiola S, Auer M, et al. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 2005; 25:551-553. (Pubitemid 40835457)
39. Cheng PJ, Huang SY, Shaw SW, et al. Difference in nuchal translucency between monozygotic and dizygotic spontaneously conceived twins. Prenat Diagn 2010; 30:247-250.
40. El Kateb A, Nasr B, Nassar M, et al. First-trimester ultrasound examination and the outcome of monochorionic twin pregnancies. Prenat Diagn 2007; 27:922-925. (Pubitemid 47597919)
41. Kagan KO, Gazzoni A, Sepulveda-Gonzalez G, et al. Discordance in nuchal translucency thickness in the prediction of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 2007; 29:527-532. (Pubitemid 46826553)
42. Sebire NJ, Snijders RJ, Hughes K, et al. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1996; 103:999-1003. (Pubitemid 26340171)
43. Chasen ST, Perni SC, Kalish RB, Chervenak FA. First-trimester risk assessment for trisomies 21 and 18 in twin pregnancy. Am J Obstet Gynecol 2007; 197:374 e1-e3.
44. Orlandi F, Rossi C, Allegra A, et al. First trimester screening with free betahCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002; 22:718-721. (Pubitemid 34857418)
45. Goncé A, Borrell A, Fortuny A, et al. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement? Prenat Diagn 2005; 25:1156-1161. (Pubitemid 43016299)
46. Hui PW, Tang MH, Ng EH, et al. Nuchal translucency in dichorionic twins conceived after assisted reproduction. Prenat Diagn 2006; 26:510-513. (Pubitemid 43989184)
47. Spencer K, Nicolaides KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. BJOG 2003; 110:276-280. (Pubitemid 36298911)
48. Spencer K, Kagan KO, Nicolaides KH. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn 2008; 28:49-52. (Pubitemid 351251990)
49. Linskens IH, Spreeuwenberg MD, Blankenstein MA, van Vugt JM. Early firsttrimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Prenat Diagn 2009; 29:74-78.
50. Chasen ST, Martinucci S, Perni SC, Kalish RB. First-trimester biochemistry and outcomes in twin pregnancy. J Reprod Med 2009; 54:312-314.
51. Linskens IH, Engels M, Oepkes D, et al. A trend toward increased first trimester free beta-hCG and PAPP-A in monochorionic twins complicated by twin-to-twin transfusion syndrome. Prenat Diagn 2010; 30:909-910.